Lee Jun-Hee, Lee Hyunjun, Bang Yoon Ju, Ryu Jai Min, Lee Se Kyung, Yu Jonghan, Lee Jeong Eon, Kim Seok Won, Nam Seok Jin, Chae Byung Joo
Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Breast Cancer. 2022 Aug;25(4):288-295. doi: 10.4048/jbc.2022.25.e36.
Surgical margin status is a surrogate marker for residual tumors after breast-conserving surgery (BCS). A comparison of ipsilateral breast tumor recurrence (IBTR) rates between re-excision combined with radiotherapy (excision with RTx) and RTx alone, following the confirmation of ductal carcinoma (DCIS) in the resection margin after BCS, has not been reported previously. Therefore, in the present study, the clinical characteristics of DCIS involvement in the surgical resection margin between excision with RTx and RTx alone were investigated, and the IBTR rate was compared.
We analyzed 8,473 patients treated with BCS followed by RTx between January 2013 and December 2019. Patients were divided into 2 groups based on surgical resection margin status in permanent pathology, and superficial and deep margins were excluded. Patients who underwent re-excision with DCIS confirmed in the resection margin were identified and the IBTR rate was examined.
Among 8,473 patients treated with BCS, 494 (5.8%) had positive surgical resection margins. The median follow-up period was 47 months. Among the 494 patients with a positive resection margin, 368 (74.5%) had residual DCIS at the surgical resection margin in the final pathology. Among those with confirmed DCIS at the resection margin, 24 patients (6.5%) were re-excised, and 344 patients (93.5%) underwent RTx after observation. The IBTR rates were 4.2% and 1.2% in the re-excision and observation groups, respectively. IBTR-free survival analysis revealed no significant difference between the excision with RTx and RTx-only groups ( = 0.262).
The IBTR rate did not differ between the excision with RTx and RTx-only groups when DCIS was confirmed at the resection margins. This suggests that RTx and close observation without re-excision could be an option, even in cases where minimal involvement of DCIS is confirmed on surgical resection.
手术切缘状态是保乳手术(BCS)后残留肿瘤的替代标志物。保乳手术后切缘确诊为导管原位癌(DCIS)后,再次切除联合放疗(切除加放疗)与单纯放疗的同侧乳腺肿瘤复发(IBTR)率比较,此前尚未见报道。因此,在本研究中,我们调查了切除加放疗与单纯放疗患者手术切缘DCIS累及的临床特征,并比较了IBTR率。
我们分析了2013年1月至2019年12月期间接受保乳手术加放疗的8473例患者。根据永久病理中的手术切缘状态将患者分为两组,排除浅切缘和深切缘。确定切缘确诊为DCIS且接受再次切除的患者,并检查IBTR率。
在8473例接受保乳手术的患者中,494例(5.8%)手术切缘阳性。中位随访期为47个月。在494例切缘阳性患者中,368例(74.5%)在最终病理中手术切缘有残留DCIS。在切缘确诊为DCIS的患者中,24例(6.5%)接受了再次切除,344例(93.5%)观察后接受了放疗。再次切除组和观察组的IBTR率分别为4.2%和1.2%。无IBTR生存分析显示,切除加放疗组与单纯放疗组之间无显著差异(P = 0.262)。
当切缘确诊为DCIS时,切除加放疗组与单纯放疗组的IBTR率无差异。这表明,即使在手术切除时确诊为DCIS累及极少的情况下,放疗和密切观察而不再次切除也可能是一种选择。